返回 Agenda
S8 - Global Regulatory Trends and Standardization Strategies for Next-Generation Alternative Technologies
Session Chair(s)
In-sook Park, PHD
Former Director General
Korean Regulatory Science Center, Korea, Republic of
Sang Aeh Park
Director
MFDS, Korea, Republic of
Speaker(s)
Beyond 3Rs: Transitioning to Human-Centric Toxicity Platforms through Regulatory Science Integration of NAMs
Joohwan Kim
NIFDS, MFDS, Korea, Republic of
Depury Director, Nonclinical Resource Research Division
Validation and Qualification of NAMs towards Regulatory Acceptance and Widespread Adoption
Danilo Tagle, PHD
National Center For Advancing Translational Sciences (NCATS), NIH, United States
Director, Office of Special Initiative
NAMs: Regulatory Science Alternatives
Dean Smith, PHD
Health Canada, Centre for Vaccines, Clinical Trials & Biostatistics, Canada
Advisor to the Director & Sr. Evaluator
Global Trends in NAMs and Industry Perspectives on Key Challenges
Ran Noh, MS
Korea Biomedicine Industry Association (KoBIA), Korea, Republic of
Team Manager
Jaeok Kim
NIFDS, MFDS, Korea, Republic of
Director, Biologics Division